Медико-биологический
информационный портал
для специалистов
 
Medline.ru

СОДЕРЖАНИЕ ЖУРНАЛА:
Физико-химическая биология

Клиническая медицина

Профилактическая медицина

Медико-биологические науки


АРХИВ:

Фундаментальные исследования

Организация здравохраниения

История медицины и биологии



Последние публикации

Поиск публикаций

Articles

Архив :  2000 г.  2001 г.  2002 г. 
               2003 г.  2004 г.  2005 г. 
               2006 г.  2007 г.  2008 г. 
               2009 г.  2010 г.  2011 г. 
               2012 г.  2013 г.  2014 г. 
               2015 г.  2016 г.  2017 г. 
               2018 г.  2019 г.  2020 г.  2021 г.  2022 г.  2023 г. 

Редакционная информация:
        Опубликовать статью
        Наша статистика


 РЕДАКЦИЯ:
Главный редактор

Заместители главного редактора

Члены редколлегии
Специализированные редколлегии


 УЧРЕДИТЕЛИ:
Институт теоретической и экспериментальной биофизики Российской академии наук.

ООО "ИЦ КОМКОН".




Адрес редакции и реквизиты

199406, Санкт-Петербург, ул.Гаванская, д. 49, корп.2

ISSN 1999-6314

Российская поисковая система
Искать: 


«
Vol. 14, Art. 46 (pp. 530-540)    |    2013       
»

Erectile dysfunction in patients on late ontogenesis:II. features of gonadostat
Odin V.I., Didenko V.I., Bologov S.G.

FGBVOU VPO "Military Medical Academy named after S.M. Kirov" Defense of the Russian Federation , St. Petersburg, Lebedeva str., 6 , E-mail : OdinVitali@mail.ru



Brief summary

The paper presents the survey data, 98 patients with erectile dysfunction ( ED) in late ontogenesis. Analyzed the results on the role of age-related androgen deficiency (ARAD ) , the level of sex hormones in the blood, testicular volume and components of the metabolic syndrome. In patients with severe ARAD found no physiological patterns between the various gonadostata. Age dependence of level testosterone in the cohort was missing, but the connection with erectile function ( EF) and the number of morning erections was a positive and significant in the group with weak ARAD.


Key words

aging, age-related androgen deficiency, erectile dysfunction





(The article in PDF format. For preview need Adobe Acrobat Reader)



Open article in new window

Reference list

1. Brown-Sequard C.E. Note on the effects produced on man by subcutaneous injections of a liquid obtained from the testicles of animals // Lancet.- 1889.Vol.2.-P.105–107


2. Hollander N., Hollander V.P. The microdetermination of testosterone in human spermatic vein blood // J. Clin. Endocr. Metab.- 1958.-Vol.19.-P. 966–970


3. Vermeulen A., Verdonck L., Rubens R. Testosterone secretion and metabolism in male senescence // J. Clin. Endocrinol. Metab.- 1972.-Vol.34.-P.730–735


4. Wu F.C.W. , Tajar A., Beynon J. et al. Identification of Late-Onset Hypogonadism in Middle-Aged and Elderly Men // N. Engl. J. Med.- 2010.-Vol.363.-P.123-35.


5. Araujo A.B. et al. Prevalence of Symptomatic Androgen Deficiency in Men // J. Clin. Endocrin. Metab.-2007.- Vol. 92.- P.4241–4247


6. Feldman H.A., Goldstein I., Hatzichristou D.G., Krane R.J., McKinlay J.B..Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study //J. Urol.- 1994.-Vol.151.-N1.-P.54-61.


7. Araujo A.B. et al. Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study // J. Clin. Endocrin.. Metab.- 2004.-Vol.89.-P.5920–5926.


8. Morales A., Lunenfeld B. Investigation, treatment and monitoring of late-onset hypogonadism in males. Official recommendations of ISSAM. International society for the study of the aging male // Aging Male.- 2002.-Vol.5.-P.151–158.


9. Chen K.K. et al. Prevalence of erectile dysfunction and impacts on sexual activity and self-reported intercourse satisfaction in men older than 40 years in Taiwan // Int. J. Impot. Res.- 2004.-Vol.16.-P. 249–255.


10. Hatzichristou D., Hatzimouratidis K., Bekas M., Apostolidis A., Tzortzis V., Yannakoyorgos K. Diagnostic steps in the evaluation of patients with erectile dysfunction // J. Urol.- 2002.-Vol.168.-P.618–620.


11. Isidori AM. et al. Critical Analysis of the Role of Testosterone in Erectile Function: From Pathophysiology to Treatment. A Systematic Review //Eur.Urol.-2013.-Vol.79.-P.123-129.


12. NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence // J.A.M.A.- 1993.Vol.270.-N1.-P.83-90.


13. Wespes E, Amar E., Hatzichristou D., Hatzimouratidis K., Montorsi F., Pryor J., Vardi Y. EAU. EAU Guidelines on erectile dysfunction: an update // Eur. Urol.- 2006.- Vol.49.-N5.-P.806-815.


14. Heinemann L.A.J. et al. The Aging Males' Symptoms (AMS) scale: update and compilation of international versions // H.Q.L.O.-2003.-Vol.1.-P.15–21


15. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction // Urology.-1997.-Vol.49.-N6.-P.822-830.


16. Dedov I.I., Kalinchenko S.U. Vozrastnoi androgennii deficit y myjchin. – M.:Prakticheskaya medicina,2006.- 240s.


17. Jockenhovet F. Male hypogonadism.- Bremen,UNI-MED.- 2004 – p.188


18. Almazov V.A., Blagosklonnaya Ya.V., Shlyahto V.V., Krasilnikova E.I. Metabolicheskii serdechno-sosydistii sindrom.- SPb.: Izd-vo SPbGMY,1999.- 208s.


19. Salam R, Kshetrimayum AS, Keisam R. Testosterone and metabolic syndrome: The link // Indian J. Endocrinol. Metab.- 2012.-Vol.16.- Suppl 1.-S12-9.


20. Kang J., Ham BK, Oh M.M, Kim J.J, Moon du G. Correlation between serum total testosterone and the AMS and IIEF questionnaires in patients with erectile dysfunction with testosterone deficiency syndrome // Korean J. Urol.- 2011.- Vol.52.-N6.-P.416-420.


21. Kaufman J. M., Vermeulen A. The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications // Endocrin. Rev.- 2005.-Vol.26.-N6.-P.833–876


22. Yassin A.A., Saad F. Testosterone and Erectile dysfunction //J. Androl.-2008.-Vol.29.-P.593–604


23. Bassil N., Alkaade S., Morle.J. The benefits and risks of testosterone replacement therapy: a review // Therap. Clin.Risk Manag.- 2009.-Vol.5.-P.427–448


24. Hajjar RR, Fran E. Kaiser and John E. Morley Outcomes of Long-Term Testosterone Replacement in Older Hypogonadal Males: A Retrospective Analysis // J.C.Endocrin.Metab.-1997.- Vol.82.-N11.-P.3793-3796


25. Le T.N. et al. III. Sex Hormone-Binding Globulin and Type 2 Diabetes Mellitus //Trends Endocrin. Metab.- 2012.-Vol.23.-N1.-P. 32–40.



Свидетельство о регистрации сетевого электронного научного издания N 077 от 29.11.2006
Журнал основан 16 ноября 2000г.
Выдано Министерством РФ по делам печати, телерадиовещания и средств массовых коммуникаций
(c) Перепечатка материалов сайта Medline.Ru возможна только с письменного разрешения редакции

Размещение рекламы

Rambler's Top100